Print Download. Examples: Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf].
|Published (Last):||14 October 2008|
|PDF File Size:||10.99 Mb|
|ePub File Size:||17.24 Mb|
|Price:||Free* [*Free Regsitration Required]|
Carcinoma hepatocelular. Na Europa, foram diagnosticados O CHC raramente ocorre antes dos 40 anos e atinge pico aproximadamente aos 70 anos. Vias moleculares do hepatocarcinoma. Estadiamento e tratamento. Conflitos de interesse. Global cancer statistics. CA Cancer J Clin. Estimates of cancer incidence and mortality in Europe in Eur J Cancer. Int J Cancer. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
J Hepatol. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Lutwick L. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma.
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Diverse roles of hepatitis B virus in liver cancer. Curr Opin Virol. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.
Am J Epidemiol. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. Obesity and cancer risk: a Danish record-linkage study.
Clinical Practice Guidelines: management of hepatitis C virus infection. Alter HJ, Houghton M. Hepatitis C virus and eliminating post-transfusion hepatitis. Nature Med. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. Calle E, Rodriguez C. A prospective study of obesity and cancer risk Sweden. Cancer Causes Control. Calle E, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.
Nat Rev Cancer. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Mutational hot spot in the p53 gene in human hepatocellular carcinomas.
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol. Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Viral hepatocarcinogenesis. Andrisani OM, Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis Review.
Int J Oncol. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss. J Biol Chem. Mol Cell Biol. Benn J, Schneider RJ. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.
Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Curr Cancer Drug Targets. Bioch Biophys Acta. TP53 and liver carcinogenesis. Hum Mutat. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Moon E-J. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun.
Hepatitis C virus-induced hepatocarcinogenesis. Molecular viral oncology of hepatocellular carcinoma. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.
Cancer Res. The role of nitric oxide in tumour progression. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression.
Corpo de Mallory
We'd like to understand how you use our websites in order to improve them. Register your interest. Surgical therapy offers the only chance for long-term cure of patients with hepatocellular carcinoma. The role of partial and total hepatectomy with subsequent liver replacement was analyzed in a consecutive series of patients. It was the aim of this study to compare both treatment modalities on the basis of various clinicopathological prognostic factors including the TNM system of pathological classification. One hundred thirty-one resections and 61 transplantations were performed for the following histological diagnoses: hepatocellular carcinoma without coexisting liver disease 86 or associated with various hepatic abnormalities 79 , fibrolamellar carcinoma 19 , and mixed hepatocholangiocellular carcinoma 8. Overall actuarial survival rates at 5 years were
Profesora, Facultad de Medicina, Universidad de los Andes. Numerosos factores de riesgo han sido identificados; sin embargo, son el VHB, el VHC y el alcohol los de mayor prevalencia en el mundo. La trama reticular se pierde en los HCC figura 6 24, Son varios los patrones arquitecturales que pueden ser observados en un hepatocarcinoma. Corresponde a un subgrupo de HCC.
Carcinoma hepatocelular. Na Europa, foram diagnosticados O CHC raramente ocorre antes dos 40 anos e atinge pico aproximadamente aos 70 anos. Vias moleculares do hepatocarcinoma.